SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

Daniel Acker — Bloomberg via Getty Images

39

Johnson & Johnson

JNJ

The 130-year old healthcare conglomerate sells everything from baby shampoo to surgical staples and cancer drugs (it also divested itself of Splenda, the artificial sweetener.) That diversification helped buoy giant J&J in 2015; the company’s strong pharmaceutical sales made up for the less impressive performances of its consumer and medical device divisions. The company’s revenues grew 2.6% in the US, but slid 5.7% worldwide in 2015, largely due to currency fluctuations and the sharp decline in sales of its Hepatitis C drug, Olysio.

CEO

Alex Gorsky

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

New Brunswick, NJ

Years on Fortune 500 List

22

Employees

127,100

Johnson & Johnson is also featured in these fortune lists
Key Financials (last fiscal year)
$ millions% change
Revenues ($M)$70,074-5.7%
Profits ($M)$15,409-5.6%
Assets ($M)$133,411
Total Stockholder Equity ($M)$71,150
Market Value — as of March 31, 2016 ($M)$298,563
Profit Ratios
Profit as % of Revenues22.0%
Profits as % of Assets11.6%
Profits as % of Stockholder Equity21.7%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)5.48
EPS % Change (from 2014)-3.9%
EPS % Change (5 year annual rate)2.8%
EPS % Change (10 year annual rate)4.7%
Total Return
Total Return to Investors (2015)1.2%
Total Return to Investors (5 year, annualized)14.2%
Total Return to Investors (10 year, annualized)8.8%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Johnson & Johnson

Bayer Shares Rise After It Ups Sales Targets for Top-Selling Drugs

Its planned $66 billion Monsanto buy had stirred criticism it might neglect its pharmaceuticals.

Read More →
What We Still Don't Know About Clinton's and Trump's Health

Both candidates have promised to release more info. Here's what we need to know.

Read More →

Videos about Johnson & Johnson

3 business lessons from Microsoft's board nominee

We sat down with Sandra Peterson, chairwoman of Johnson & Johnson, at this year's Most Powerful Women Summit. Here are some lessons she learned over the years.

Read More →
How to become the World's Most Admired Company

Fortune released it's World's Most Admired Companies list, take a look at who made the top ten.

Read More →
How to look like you know what you're doing

These Fortune 500 executives explain how they stay on top of their busy schedule.

Read More →
7 tips on climbing the corporate ladder

Seven women executives from Fortune's Most Powerful Women community give their best career advice.

Read More →